The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Records revenue growth of 22% to Rs. 762 crores in Q4 FY23 and grew 30% to Rs. 3149 crores in FY23
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
Women of all ages will get round-the-clock access to comprehensive treatment
Medical Tourism will boost India’s economy
Having a healthy gut is key as it permits the body to build a stronger immune system
68% of children on a higher dose of Dupixent achieved histological disease remission at week 16
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
The company is focused on therapies such as skinceuticals, gastroenterology, neuropsychiatry, cardiac diabetes care etc.
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Subscribe To Our Newsletter & Stay Updated
